Titan Medical WKN: A2JN66 ISIN: CA88830X8199 Kürzel: QTNA
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
Anzeige
![Smartbroker]()
Alles ab 0 Euro pro Order. Dauerhaft.
Summer.76,
12. Mai 15:14
https://finance.yahoo.com/news/titan-medical-reports-financial-results-113000083.html
Summer.76,
3. Mai 15:18
https://www.streetinsider.com/dr/news.php?id=20005207&gfv=1
Summer.76,
3. Mai 15:13
https://www.businesswire.com/news/home/20220503005606/en/Titan-Medical-Announces-Purchase-Order-from-Medtronic
Titan Medical Announces Purchase Order from Medtronic
Summer.76,
24. Mär 14:06
Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2021
Completed Final Milestone with Medtronic
Selected Benchmark to Manufacture Enos System
Expanded Patent Portfolio to More Than 200
https://www.businesswire.com/news/home/20220324005157/en/Titan-Medical-Reports-Operating-and-Financial-Results-for-the-Fourth-Quarter-and-Year-End-2021
Summer.76,
07.02.2022 13:37
Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy
https://www.businesswire.com/news/home/20220207005169/en/Titan-Medical-Expands-Patent-Portfolio-to-More-Than-200-Patents-and-Applications-and-Clarifies-Third-Party-Licensing-Strategy
A
Alien91,
03.02.2022 20:14
Schwierige frage, gibt halt zur zeit null anhaltspunkte, vor allem was das mit medtronic betrifft
S
Schulzelsholz,
03.02.2022 12:59
Was denkt ihr? Wie wird es weitergehen?
BobReben1962,
26.01.2022 19:09
Das halbe inflarx Forum
BobReben1962,
26.01.2022 19:07
Ich auch
BO66,
26.01.2022 19:06
Hallo da bin ich....😁
|
|
Kommentare | ||
|---|---|---|---|
| 1 | TITAN MEDICAL Hauptdiskussion |
Kursdetails
| Geld (bid) | 0,4260 (4.717) |
|---|---|
| Brief (ask/offer) | 0,4350 (4.717) |
| Spread | 2,0690 |
| Geh. Stück | 0 |
| Eröffnung | 0,4305 |
| Vortag | 0,4240 |
| Tageshoch | 0,4305 |
| Tagestief | 0,4305 |
| 52W Hoch | 1,7650 |
| 52W Tief | 0,3605 |
Tagesvolumen
| in EUR gehandelt | 0 Stk |
|---|---|
| in USD gehandelt | 76.416 Stk |
| in GBP gehandelt | 0 Stk |
| in CAD gehandelt | 15.320 Stk |
| Gesamt | 91.736 Stk |
Anzeige
![Smartbroker]()
Der Broker von Deutschlands größter Finanzcommunity
Geld/Brief Kurse
| Börse | Geld | Brief | Zeit | Volumen | Kurs |
|---|---|---|---|---|---|
| Frankfurt | 0,4098 | 0,4537 | 1653026420 20. May | 0,3900 EUR | |
| Berlin | 0,3698 | 0,4937 | 1653075511 20. May | 0,4244 EUR | |
| Düsseldorf | 0,4127 | 0,4355 | 1653037241 20. May | 0,3838 EUR | |
| Stuttgart | 0,4129 | 0,4607 | 1653068272 20. May | 0,4130 EUR | |
| Nasdaq | 0,4403 | 0,4550 | 1653091200 02:00 | 76.316 Stk | 0,4550 USD |
| AMEX | 1653091200 02:00 | 100 Stk | 0,4436 USD | ||
| Tradegate | 0,4046 | 0,4439 | 1653078434 20. May | 0,4241 EUR | |
| Lang & Schwarz | 0,4260 | 0,4350 | 1653130754 12:59 | 0,4305 EUR | |
| London | 1651764926 5. May | 0,4291 GBP | |||
| Toronto | 0,5700 | 0,6500 | 1653076581 20. May | 15.320 Stk | 0,5700 CAD |
| Gettex | 0,4098 | 0,4537 | 1653075781 20. May | 0,4391 EUR | |
| Baader Bank | 0,4098 | 0,4537 | 1653076757 20. May | 0,4245 EUR | |
| TTMzero RT | 1653076801 20. May | 0,4243 EUR | ges. 91.736 Stk |
Realtime / Verzögert
Börsennotierung
| Marktkapitalisierung in EUR |
|---|
| 47,1 Mio. |
| Anzahl der Aktien |
| 111,2 Mio. |
Grundlegende Daten zur TITAN MEDICAL Aktie
| Finanzdaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
|---|---|---|---|---|---|---|---|
| KUV | - | - | - | - | - | - | - |
| Ergebnis je Aktie (bereinigt) | - | - | - | - | - | - | - |
| Cashflow | - | - | - | - | - | - | - |
| Eigenkapitalquote | - | - | - | - | - | - | - |
| Verschuldungsgrad | - | - | - | - | - | - | - |
| Eigenkapitalrendite | - | - | - | - | - | - | - |
| Gesamtkapitalrendite | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - |
| Fundamentaldaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
| KCV | - | - | - | - | - | - | - |
| Dividendenrendite | - | - | - | - | - | - | - |
| Kurs-Gewinn-Verhältnis (KGV) | - | - | - | - | - | - | - |
| Dividende je Aktie | - | - | - | - | - | - | - |
| Bilanzdaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
| Netto-Provisionsüberschuss | - | - | - | - | - | - | - |
| Umsatzerlöse | - | - | - | - | - | - | - |
| Ergebnis vor Steuern | - | - | - | - | - | - | - |
| Steuern | - | - | - | - | - | - | - |
| Ausschüttungssumme | - | - | - | - | - | - | - |
| Nettoverzinsung | - | - | - | - | - | - | - |
| Zinsertrag | - | - | - | - | - | - | - |
| Gesamtertrag | - | - | - | - | - | - | - |